Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.3K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

166
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
166
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

244
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
244
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

377
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
377
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
110

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Needle Types and Diagnostic Accuracy in EUS-Guided Liver Biopsy: A Systematic Review and Network Meta-Analysis.

Diagnostics (Basel, Switzerland)·2026
Same author

The Gut Microbiota: A Functional Hub Linking Nutrition, Immunity, and Cardiovascular Health.

Reviews on recent clinical trials·2026
Same author

Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic Review.

Current allergy and asthma reports·2026
Same author

Unraveling the Complexities of Small Intestinal Bacterial Overgrowth.

Medicina (Kaunas, Lithuania)·2026
Same author

Endoscopic Management of Post-Bariatric Surgery Complications: Diagnostic Work-Up and Innovative Approaches for Leak, Fistula, and Stricture Management.

Diagnostics (Basel, Switzerland)·2026
Same author

Impact of Oral Administration of <i>Lactobacillus reuteri</i> LMG-P 27481 on Human Gut Microbiota Diversity and Function: A Pilot Study.

Biomedicines·2025

Related Experiment Video

Updated: Jun 3, 2025

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

5.9K

Gut Microbiome Implication and Modulation in the Management of Recurrent Urinary Tract Infection.

Mattia Brigida1, Angela Saviano2, Carmine Petruzziello3

  • 1Gastroenterology Department, Policlinico Tor Vergata, 00133 Rome, Italy.

Pathogens (Basel, Switzerland)
|January 8, 2025
PubMed
Summary

Urinary tract infections (UTIs) are linked to gut health. Gut dysbiosis, particularly an overgrowth of E. coli, increases UTI risk and antibiotic resistance, suggesting UTIs may be a gut-related condition.

Keywords:
Escherichia coliUTIantibioticsgut microbiotagut–bladder axismicrobiomeprobioticsurinary tract infectionurobiome

More Related Videos

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.0K
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.1K

Related Experiment Videos

Last Updated: Jun 3, 2025

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

5.9K
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.0K
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.1K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Urinary tract infections (UTIs) are common bacterial infections with high incidence, particularly in women.
  • Pathogens causing UTIs often originate from the gut, and gut dysbiosis is increasingly recognized in UTI pathogenesis.
  • Recent advancements in diagnostics have improved understanding of urinary tract microbial communities.

Purpose of the Study:

  • To review recent studies on the gut-urinary microbiome association.
  • To summarize the impact of gut and urinary microbial interactions on UTI development.
  • To explore novel therapeutic strategies, including probiotics, for UTIs.

Main Methods:

  • Review of recent scientific literature on gut microbiota, urinary microbiome, and UTIs.
  • Analysis of diagnostic techniques like quantitative urine culture and next-generation sequencing.
  • Synthesis of current knowledge on microbial community interactions and their role in UTI pathogenesis.

Main Results:

  • Gut dysbiosis is a significant factor in UTI development.
  • Escherichia coli (E. coli) from the gut is a primary UTI pathogen; its overgrowth is a risk factor.
  • The gut microbiota harbors antibiotic resistance genes, impacting UTI treatment.
  • The urinary tract harbors its own microbiome, challenging the notion of a sterile environment.

Conclusions:

  • UTIs should be viewed as potentially gut-related conditions, not solely urinary ones.
  • Understanding the interplay between gut and urinary microbiomes offers new therapeutic avenues.
  • Probiotics show promise as a therapeutic option for managing UTIs.